Atossa Therapeutics
ATOS
ATOS
73 hedge funds and large institutions have $25M invested in Atossa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 33 reducing their positions, and 24 closing their positions.
Holders
73
Holders Change
-10
Holders Change %
-12.05%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
7
Reduced
33
Closed
24
Calls
$1.92M
Puts
$2.05M
Net Calls
-$137K
Net Calls Change
+$166K
Top Buyers
| 1 |
LCM
1
Laurion Capital Management
New York
|
$2.43M |
| 2 |
2
Millennium Management
New York
|
$1.67M |
| 3 |
E
3
Ergoteles
New York
|
$561K |
| 4 |
SM
4
Sabby Management
Miami Beach,
Florida
|
$572K |
| 5 |
5
Morgan Stanley
New York
|
$291K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.91M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$0 |
| 3 |
3
State Street
Boston,
Massachusetts
|
$524K |
| 4 |
4
D.E. Shaw & Co
New York
|
$2.49M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$266K |
